Brief: Allurion Announces Strategic Distribution Partnership With Prosurg Medical In Brazil To Pioneer New Approach Focused On Metabolically Healthy Weight Loss
18/11/2025 14:06
Allurion Technologies Inc ALUR.N: ALLURION ANNOUNCES STRATEGIC DISTRIBUTION PARTNERSHIP WITH PROSURG MEDICAL IN BRAZIL TO PIONEER NEW APPROACH FOCUSED ON METABOLICALLY HEALTHY WEIGHT LOSS ALLURION TECHNOLOGIES INC - PARTNERSHIP TO INCREASE ACCESS TO ALLURION PROGRAM WITH GLP-1 THERAPY Source text: ID:nBw2c4TWCa Further company coverage: ALUR.N
Recent news on Allurion Technologies
See all newsBrief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
Brief: NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc.
Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina
Allurion rises after strong weight-loss data from combination therapy